Home AbbVie to buy leukemia drugmaker Pharmacyclics for $21B
 

Keywords :   


AbbVie to buy leukemia drugmaker Pharmacyclics for $21B

2015-03-06 06:29:46| Food - Topix.net

AbbVie will spend about $21 billion to buy fellow drugmaker Pharmacyclics and add another major revenue producer to a portfolio that already includes the world's top-selling drug. The deal will give the North Chicago, Ill., drugmaker Imbruvica, a blood cancer treatment that Pharmacyclics makes and then markets with Johnson & Johnson's Janssen Biotech.

Tags: buy leukemia 21b drugmaker

Category:Food and Related Products

Latest from this category

All news

»
26.06Universal UK resort to open 365 days a year
26.06Eastern North Pacific Tropical Weather Outlook
26.06Atlantic Tropical Weather Outlook
26.06VW to invest up to $5bn in Tesla rival Rivian
26.06Strategic use of soybean meal to maximize hog carcass weight during summer
26.06Eastern North Pacific Tropical Weather Outlook
26.06Atlantic Tropical Weather Outlook
26.06Aer Lingus pilots begin industrial action over pay dispute
More »